Pemphigus foliaceus and acquired haemophilia: a rare but important association with life-threatening consequences

Clin Exp Dermatol. 2018 Oct;43(7):825-828. doi: 10.1111/ced.13617. Epub 2018 May 19.

Authors

A G Wernham¹, C Peng¹, B Bailiff², A Ilchyshyn¹

Affiliations

¹ Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Foundation TrustCoventry, Clifford Bridge Road, CV2 2DX, UK.
² Department of Haematology, University Hospitals Coventry and Warwickshire NHS Foundation TrustCoventry, Clifford Bridge Road, CV2 2DX, UK.

PMID: 29777540
DOI: 10.1111/ced.13617

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Intravenous
Anti-Inflammatory Agents / therapeutic use
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use
Female
Hemophilia A / blood
Hemophilia A / diagnosis*
Hemophilia A / etiology
Hemophilia A / therapy
Humans
Immunologic Factors / therapeutic use
Immunosuppressive Agents / therapeutic use
Middle Aged
Pemphigus / blood
Pemphigus / complications*
Pemphigus / drug therapy
Pemphigus / pathology
Prednisolone / administration & dosage
Prednisolone / therapeutic use
Rituximab / administration & dosage
Rituximab / therapeutic use*
Treatment Outcome

Substances

Anti-Inflammatory Agents
Immunologic Factors
Immunosuppressive Agents
Rituximab
Cyclophosphamide
Prednisolone

Supplementary concepts

Factor 8 deficiency, acquired